Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Development and manufacture of HI-6 DMS powder for solution product. The Authority requires a supplier to provide services for the development, scale-up, clinical and potential future commercial supply. The supplier will be providing product into UK, Canadian and European Union regulatory areas as a minimum. The supplier will provide all supporting manufacturing studies necessary for all stages of product development. The product should be considered light sensitive for the purposes of long-term storage but specific measures should not be necessary for production processes. The Authority will provide the Active Pharmaceutical to the supplier for all activities.
No supplier information available.